Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 4/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8352036 | 0.92 | OPRM1 (0.37) | OPRM1SPHK1LMNADNM1ADH1B | |
| Ammonia Solution, Strong SCHEMBL27724067 | 0.92 | OPRM1 (0.37) | OPRM1SPHK1LMNADNM1ADH1B | |
| Ammonia Solution, Strong SCHEMBL23781137 | 0.87 | LMNA (0.39) | OPRM1SPHK1LMNACA2ACE2 | |
| Ammonia Solution, Strong SCHEMBL27265916 | 0.86 | OPRM1 (0.38) | OPRM1SPHK1LMNADNM1ADH1B | |
| Ammonia Solution, Strong SCHEMBL2112296 | 0.86 | OPRM1 (0.38) | OPRM1SPHK1LMNADNM1ADH1B | |
| SCHEMBL28871402 | 0.83 | OPRM1 (0.39) | OPRM1SPHK1LMNADNM1ADH1B | |
| Ammonia Solution, Strong SCHEMBL6063880 | 0.83 | OPRM1 (0.31) | OPRM1SPHK1 | |
| Ammonia Solution, Strong SCHEMBL766319 | 0.81 | FDPS (0.33) | SPHK1LMNACA2ACE2FDPS | |
| Ammonia Solution, Strong SCHEMBL2365711 | 0.81 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1ADH1B | |
| Ammonia Solution, Strong SCHEMBL5819817 | 0.81 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008097599-A2 | ANTIMICROBIAL BLOOD PRESSURE CUFF LINER | MCCAUGHEY ELIZABETH (US) | 2008-08-14 | — | — | WO | claimed |
| US-12565567-B2 | Multifunctional smart particles | SYNMATTER LLC (US) | 2026-03-03 | — | — | US | disclosed |
| US-20250143930-A1 | Medical Adhesives For Quick Release Of Antimicrobials | AVERY DENNISON CORPORATION | 2025-05-08 | — | — | US | disclosed |
| US-12245919-B2 | Medical adhesives for quick release of antimicrobials | AVERY DENNISON CORPORATION (US) | 2025-03-11 | — | — | US | disclosed |
| EP-3806915-B1 | MEDICAL ADHESIVES FOR QUICK RELEASE OF ANTIMICROBIALS | AVERY DENNISON CORP (US) | 2024-11-20 | — | — | EP | disclosed |
| US-12109319-B2 | Rubber-based soft gel skin adhesives | AVERY DENNISON CORPORATION (US) | 2024-10-08 | — | — | US | disclosed |
| US-20240239968-A1 | Multifunctional Smart Particles | SYNMATTER LLC (US) | 2024-07-18 | — | — | US | disclosed |
| US-11926716-B2 | Multifunctional smart particles | SYNMATTER LLC (US) | 2024-03-12 | — | — | US | disclosed |
| EP-4192531-A1 | FORTIFIED SANITIZING COMPOSITION HAVING ANTIMICROBIAL CHARACTERISTICS | 2 V Industries, Inc. (US) | 2023-06-14 | — | — | EP | disclosed |
| US-20230120425-A1 | Multifunctional Smart Particles | SYNMATTER LLC (US) | 2023-04-20 | — | — | US | disclosed |
| WO-2021234463-A1 | FORTIFIED SANITIZING COMPOSITION HAVING ANTIMICROBIAL CHARACTERISTICS | 2 V Industries, Inc. (US) | 2021-11-25 | — | — | WO | disclosed |
| EP-2898001-B1 | TEXTILE TREATMENT COMPOUNDS AND COMPOSITIONS | DEVAN CHEMICALS NV (BE) | 2019-08-07 | — | — | EP | disclosed |
| WO-2018237077-A1 | ANTIMICROBIAL SPONGES | ALLIED BIOSCIENCE, INC. (US) | 2018-12-27 | — | — | WO | disclosed |
| EP-3297435-A1 | METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILMS ON ANIMAL TISSUES | REDUXX LLC (US) | 2018-03-28 | — | — | EP | disclosed |
| WO-2016187391-A1 | METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILMS ON ANIMAL TISSUES | HILLIARD CARL (US) | 2016-11-24 | — | — | WO | disclosed |
| WO-2015038606-A1 | ANTIMICROBIAL COMPOSITIONS AND METHOD | KRAFFT RANDALL W (US) | 2015-03-19 | — | — | WO | disclosed |
| WO-2014153349-A1 | WATER TREATMENT AND PURIFICATION SYSTEM AND METHODS | R&R REGESTER ENTERPRISES, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2002075220-A1 | AIR TREATMENT UNITS | DWYER ROBERT CHARLES (GB) | 2002-09-26 | — | — | WO | disclosed |
| EP-0426177-A1 | Process for preparing quaternary ammonium compounds | SHEREX CHEMICAL COMPANY, INC. (US) | 1991-05-08 | — | — | EP | disclosed |
| EP-0279623-A2 | Silane microemulsions | DOW CORNING CORPORATION (US) | 1988-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565567-B2 | Multifunctional smart particles | KCNN3, KCNN1, KCNN2 | OPRM1 4548/4885SPHK1 561/4885LMNA 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.